Supplement Table S4 from Lipid Nanoparticle–Encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36γ plus Durvalumab Induces an Immunostimulatory Effect within the Tumor Microenvironment in Patients with Advanced Solid Tumors

Authors: Randy F. Sweis, Georgina V. Long, Adil Daud et al.

Publication:

Published: Unknown date

Source: Crossref

Abstract

<jats:p><p>Pharmacokinetic Exposures of mRNA-2752 components (IL-23, IL-36γ, and OX40L) by Dose of mRNA-2752.</p></jats:p>

ppharmacokinetic exposures mrna2752 components il23